Founded in 2002 and headquartered in Columbia, Maryland, with more than 300 employees in the United States, ACell, Inc. is a leading developer, manufacturer, and marketer of next-generation regenerative medicine products. ACell offers their regenerative medicine products through the development and commercialization of unique extracellular matrix medical devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. ACell medical devices are cleared for a variety of indications and are marketed under the brand name "MatriStem." A privately held company, ACell produces MatriStem at its full scale manufacturing facilities in Columbia, MD and Lafayette, IN, and markets its products to physicians in the U.S. through a national direct sales force.